vitamin k 3 has been researched along with Amyotrophic Lateral Sclerosis in 1 studies
Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veyrat-Durebex, C | 1 |
| Corcia, P | 1 |
| Piver, E | 1 |
| Devos, D | 1 |
| Dangoumau, A | 1 |
| Gouel, F | 1 |
| Vourc'h, P | 1 |
| Emond, P | 1 |
| Laumonnier, F | 1 |
| Nadal-Desbarats, L | 1 |
| Gordon, PH | 1 |
| Andres, CR | 1 |
| Blasco, H | 1 |
1 other study available for vitamin k 3 and Amyotrophic Lateral Sclerosis
| Article | Year |
|---|---|
Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Cell Line; Cell Survival; Citric Acid Cycle; Coculture Techniques; Di | 2016 |